<div><p>Background</p><p>In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania.</p><p>Methods</p><p>A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (≥15 years) were interviewed about personal char...
Abstract Background Mass drug administration (MDA) has been one of the strategies endorsed by the Wo...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...
In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mas...
This article documents understandings and responses to mass drug administration (MDA) for the treatm...
This article documents understandings and responses to mass drug administration (MDA) for the treatm...
Copyright @ 2012 The Authors. This is an open-access article distributed under the terms of the Crea...
Copyright @ 2012 Cambridge University PressSummary This article documents understandings and respons...
Abstract Background Understanding factors surrounding the implementation process of mass drug admini...
This descriptive cross sectional study was carried out in Mkuranga District, Coast Region during th...
The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual mass drug adm...
Background: The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual m...
Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filar...
In most countries of sub-Saharan Africa the control of lymphatic filariasis (LF) is based on annual ...
<div><p>Background</p><p>The success of programs to eliminate lymphatic filariasis (LF) depends in l...
Abstract Background Mass drug administration (MDA) has been one of the strategies endorsed by the Wo...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...
In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mas...
This article documents understandings and responses to mass drug administration (MDA) for the treatm...
This article documents understandings and responses to mass drug administration (MDA) for the treatm...
Copyright @ 2012 The Authors. This is an open-access article distributed under the terms of the Crea...
Copyright @ 2012 Cambridge University PressSummary This article documents understandings and respons...
Abstract Background Understanding factors surrounding the implementation process of mass drug admini...
This descriptive cross sectional study was carried out in Mkuranga District, Coast Region during th...
The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual mass drug adm...
Background: The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual m...
Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filar...
In most countries of sub-Saharan Africa the control of lymphatic filariasis (LF) is based on annual ...
<div><p>Background</p><p>The success of programs to eliminate lymphatic filariasis (LF) depends in l...
Abstract Background Mass drug administration (MDA) has been one of the strategies endorsed by the Wo...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...
BackgroundDespite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic f...